Maximizing the productivity, growth, and viability of CHO cell lines is an integral part of the development and commercialization of biotherapeutics. To help ensure this, the BalanCD CHO Media Platform delivers a scalable platform of chemically-defined, animal component-free growth and feed media that foster consistent growth and production at all phases:
|Discovery||Transfectory||Delivers milligram- to gram-scale yield of recombinant proteins using a simplified and affordable protocol|
|Cell Line Development||Growth A and Media Survey Panel||Delivers milligram- to gram-scale yield of recombinant proteins using a simplified and affordable protocol|
|Process Development & Scale-up||Growth A and Custom Media Services||Delivers higher protein titer and formulated to support full-scale commercial manufacturing|
|cGMP Manufacturing||Feed 4||Boost manufacturing outcomes with the growth and performance benefits of our most advanced, high-nutrient feed medium|
Purpose-built BalanCD CHO growth and feed media are formulated for industrial applications and for a smooth transition from early stage into commercial bioproduction. Scalability to a commercial batch size is ensured using a Rational Culture Media Design approach of sequential, complementary development methods to leverage our scientists’ knowledge of the effects of components and process parameters.
Designed to nurture and advance every step of development, the BalanCD CHO Media Platform provides reliable, consistent results from discovery to commercialization.
Serum-free and chemically-defined media are lower in protein content than media supplemented with serum, which can simplify the purification process and increase the yield of the end product. These media are free of animal-derived components, and only contain known chemical components.
Feed media are designed to provide cell culture nutrients for fed-batch process applications.